Morning Trend | Recursion Pharmaceuticals fluctuates within a range, short-term main force's lurking signal gradually strengthens?

Recursion Pharmaceuticals (RXRX.US) experienced a low-level tug-of-war yesterday, repeatedly contesting in the range of $1.7 to $2.2. The pharmaceutical sector as a whole remains quiet, with capital positions in the sector being compressed, and signs of main forces lurking in the community are gradually emerging. The MACD is suppressing elasticity, and the RSI is approaching the oversold zone. Short-term main forces are attempting to digest selling pressure with small orders, leading to gradually increasing volatility during the session. There are no new announcements to catalyze the pharmaceutical sector, with financing positions withdrawing and retail investors' willingness to follow suit cooling down. Whether RXRX can lead a counterattack has sparked heated discussions in the community. Trading volume remains persistently low, currently controlled by swing traders who are observing. However, if trading suddenly expands significantly during the session, there may be a trend of short-term main forces igniting counterattack momentum. During periods of unusual activity, volatile funds can easily take advantage of volume rebounds for arbitrage, and opportunities can be fleeting. Today, attention should be paid to whether there is a rapid replenishment of volume and main forces lifting prices during intraday trading. Once a recovery trend is established, short-term funds may consider increasing positions; otherwise, a defensive approach is still necessary. The sector's hot spots are switching slowly, with weak momentum for continuous rallies, and it is advisable to enter and exit quickly when opportunities arise. The signals of short-term main forces lurking are gradually strengthening, and traders are waiting for movements during the session